A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia
Clinical trial NCT06173570 · COMPLETED
Trial details
- NCT number
- NCT06173570
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-19
- Primary completion
- 2024-09-30
- Enrollment
- 428
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.